Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention

被引:20
作者
Bath, Philip M. W. [1 ]
Hogg, Cheryl [1 ]
Tracy, Michael [1 ]
Pocock, Stuart [1 ]
机构
[1] Univ Nottingham, Div Stroke Med, Nottingham NG5 1PB, England
基金
英国医学研究理事会;
关键词
acute stroke; methodology; numbers-needed-to-treat; randomized-controlled trial; rehabilitation; stroke prevention; TISSUE-PLASMINOGEN ACTIVATOR; ENTIRE RANGE; THROMBOLYTIC THERAPY; ISCHEMIC-STROKE; NXY-059; DIPYRIDAMOLE; DERIVATION; SHIFTS; SCALES;
D O I
10.1111/j.1747-4949.2011.00614.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Number-needed-to-treat describes the magnitude of the effect of an intervention, underpins health economic analyses, and is typically calculated for binary events. Ordered categorical outcomes provide more clinical information and their analysis using ordinal approaches is usually more efficient statistically. However, to date, techniques to calculate number-needed-to-treat based on ordinal outcomes for parallel group trials have had important limitations. Aims Numbers-needed-to-treat may be calculated for ordinal data from parallel group trials by using an unmatched comparison of all subjects or by generating matched pairs of patients nested within the study. Methods The above approaches were assessed and compared with numbers-needed-to-treat calculated for binary outcomes using individual patient data from acute and prevention stroke trials testing the effect of interventions of varying utility and efficacy. Results Numbers-needed-to-treat were generally lower numerically for ordinal vs. binary, and matched vs. unmatched analyses, and the lowest in highly efficacious interventions: hemicraniectomy, ordinal matched 2.4 vs. ordinal unmatched 2.5 vs. binary matched 12 vs. binary unmatched 9 (one trial, 12 month outcome); alteplase, 4.5 vs. 6.6 vs. 8.4 vs. 8.4 (one trial with two parts, three-months); aspirin, 42 vs. 58 vs. 76 vs. 80 (one trial, six-months); and stroke units, 3.6-5.3 vs. 6.2 vs. 4.75.9 vs. 6.3-7.0 (two trials, three-to 60 months). Similar trends were seen for aspirin/dipyridamole vs. aspirin in secondary prevention, 22 vs. 20 vs. 31 vs. 31 (one trial, 24 months). Conclusions Number-needed-to-treat may be calculated for ordinal outcome data derived from parallel group stroke trials; such numbers-needed-to-treat are lower than those calculated for binary outcomes. Their use complements the use of ordinal statistical approaches in the analysis of ordered categorical data.
引用
收藏
页码:472 / 479
页数:8
相关论文
共 32 条
  • [1] Bath P.M., 2001, COCHRANE DB SYST REV
  • [2] Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors?
    Bath, Philip
    Gray, Laura J.
    Collier, Timothy
    [J]. STROKE, 2009, 40 (03) : 888 - 894
  • [3] Use of ordinal outcomes in vascular prevention trials - Comparison with binary outcomes in published trials
    Bath, Philip M. W.
    Geeganage, Chamila
    Gray, Laura J.
    Collier, Timothy
    Pocock, Stuart
    [J]. STROKE, 2008, 39 (10) : 2817 - 2823
  • [4] Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials
    Bath, Philip M. W.
    [J]. STROKE, 2007, 38 (06) : 1911 - 1915
  • [5] Bath PMW, 2000, STROKE, V31, P2257
  • [6] European stroke prevention study .2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    Diener, HC
    Cunha, L
    Forbes, C
    Sivenius, J
    Smets, P
    Lowenthal, A
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) : 1 - 13
  • [7] Interpreting treatment effects in randomised trials
    Guyatt, GH
    Juniper, EF
    Walter, SD
    Griffith, LE
    Goldstein, RS
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7132) : 690 - 693
  • [8] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    Hacke, Werner
    Kaste, Markku
    Bluhmki, Erich
    Brozman, Miroslav
    Davalos, Antoni
    Guidetti, Donata
    Larrue, Vincent
    Lees, Kennedy R.
    Medeghri, Zakaria
    Machnig, Thomas
    Schneider, Dietmar
    von Kummer, Ruediger
    Wahlgren, Nils
    Toni, Danilo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1317 - 1329
  • [9] The effect of a stroke rehabilitation unit on functional and psychological outcome: A randomised controlled trial
    Juby, LC
    Lincoln, NB
    Berman, P
    [J]. CEREBROVASCULAR DISEASES, 1996, 6 (02) : 106 - 110
  • [10] Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR